LINC01624: A Potential Drug Target and Biomarker (G401289)

Target Name: LINC01624

NCBI ID: G401289

LINC01624

Other Name(s): long intergenic non-protein coding RNA 1624 | TCONS_00011425 | Long intergenic non-protein coding RNA 1624

LINC01624: A Potential Drug Target and Biomarker

LINC01624 is a long intergenic non-protein coding RNA (lncRNA) that has been identified as a potential drug target or biomarker. It is a non-coding RNA molecule that is located between the 5' and 3' ends of a protein coding gene, and is typically expressed in a very low abundance.

LINC01624 is made up of 19 exons, and its protein coding gene has a predicted localization of 51 amino acids upstream and 54 amino acids downstream. It is located on chromosome 6, at position 118.35 + strand 1.

The function of LINC01624 is not yet fully understood, but it is thought to play a role in the regulation of gene expression. It is possible that it acts as a scaffold to recruit chromatin remodeling complexes to specific genomic locations, where it can then interact with transcription factors and other non-coding RNAs to regulate gene expression.

LINC01624 is also of interest as a potential drug target, due to its unique expression pattern and the fact that it is not highly abundant in the human body. It is possible that targeting LINC01624 could be a useful way to treat a variety of diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

In addition to its potential as a drug target, LINC01624 also has potential as a biomarker. Its expression is often reduced in a variety of diseases, including neurodegenerative disorders, which makes it a potential indicator of disease severity or the effectiveness of a given treatment.

Overall, LINC01624 is a promising candidate for further research as a drug target or biomarker. Further studies are needed to fully understand its function and potential clinical applications.

Protein Name: Long Intergenic Non-protein Coding RNA 1624

The "LINC01624 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01624 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets